• Explore /
  • Poster
  • / NEO-CESQ study: Neoadjuvant plus adjuvant treatment with cemiplimab in surgically resectable, high risk stage III/IV (M0) cutaneous squamous cell carcinoma.

NEO-CESQ study: Neoadjuvant plus adjuvant treatment with cemiplimab in surgically resectable, high risk stage III/IV (M0) cutaneous squamous cell carcinoma.

Abstract Poster

Authors

Paolo Antonio Ascierto

Paolo Antonio Ascierto

Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy

Paolo Antonio Ascierto , Paolo Bossi , Mario Mandalà , Paola Queirolo , Francesco Spagnolo , Franco Bassetto , Vittorio Rampinelli , Francesco Giovacchini , Elisabetta Pennacchioli , Corrado Caraco , Gianpiero Parrinello , Domenico Mallardo , Diana Giannarelli , Claudia Trojaniello , Daniela Massi , Vanna Chiarion-Sileni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT04632433

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 9576)

DOI

10.1200/JCO.2023.41.16_suppl.9576

Abstract #

9576

Poster Bd #

339

Abstract Disclosures

Similar Posters

First Author: Michael C. Lowe

First Author: Antonella Cammarota

First Author: Xiao Yang

First Author: yueyun chen